| |
| |
|
| Insider
Information: |
Langer Dennis |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
21,160,866 |
|
|
Indirect Shares
|
47,978 |
|
|
| Direct
Value |
$12,167,672 |
|
|
|
Indirect Value
|
$1,833,719 |
|
|
| Total
Shares |
21,208,844 |
|
|
| Total
Value |
$14,001,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Director |
2022-06-02 |
106,802 |
2007-12-19 |
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
|
2018-08-15 |
29,064 |
2018-08-15 |
47,978 |
Premium* |
|
|
Delcath Systems Inc |
DCTH |
Director |
2015-06-10 |
20,000 |
2015-06-10 |
0 |
Premium* |
|
|
Cellect Biotechnology Ltd |
APOP |
Director |
2023-01-01 |
21,005,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APOP |
Cellect Biotechnology Ltd |
Director |
– • – |
2023-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,005,000 |
|
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,275 |
106,802 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2021-08-03 |
4 |
AS |
$34.75 |
$1,042,500 |
D/D |
(30,000) |
89,527 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2021-08-03 |
4 |
OE |
$25.39 |
$761,700 |
D/D |
30,000 |
119,527 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,848 |
89,527 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2020-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
15,889 |
76,679 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2019-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,687 |
60,790 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
9,360 |
49,103 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
|
• • – |
2018-08-15 |
4 |
AS |
$16.00 |
$380,960 |
I/I |
(23,810) |
47,978 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
|
• • – |
2018-08-15 |
4 |
AS |
$16.00 |
$232,496 |
D/D |
(14,531) |
29,064 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-08 |
4 |
S |
$39.35 |
$537,678 |
D/D |
(13,664) |
39,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-08 |
4 |
OE |
$21.29 |
$290,907 |
D/D |
13,664 |
53,407 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-07 |
4 |
S |
$39.35 |
$121,828 |
D/D |
(3,096) |
39,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-07 |
4 |
OE |
$21.29 |
$65,914 |
D/D |
3,096 |
42,839 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-06 |
4 |
S |
$39.37 |
$142,088 |
D/D |
(3,609) |
39,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-06 |
4 |
OE |
$21.29 |
$76,836 |
D/D |
3,609 |
43,352 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-05 |
4 |
AS |
$39.90 |
$48,957 |
D/D |
(1,227) |
39,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-05 |
4 |
OE |
$21.29 |
$26,123 |
D/D |
1,227 |
40,970 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-04 |
4 |
AS |
$39.90 |
$734,320 |
D/D |
(18,404) |
39,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-04 |
4 |
OE |
$21.29 |
$422,821 |
D/D |
18,404 |
48,147 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-01 |
4 |
AS |
$38.90 |
$1,167,000 |
D/D |
(30,000) |
39,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-06-01 |
4 |
OE |
$24.40 |
$732,000 |
D/D |
30,000 |
69,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-05-30 |
4 |
AS |
$37.92 |
$379,245 |
D/D |
(10,000) |
39,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-05-30 |
4 |
OE |
$24.39 |
$243,900 |
D/D |
10,000 |
49,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-05-21 |
4 |
OE |
$24.39 |
$243,900 |
D/D |
10,000 |
49,743 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
